secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELUTIA INC. (ELUT)
CIK:        0001708527
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0001104659-23-058445
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aziyo reports record Q1 sales $13.1M; Nasdaq warns MVLS below $35M
------------------------------------------------------------------

- Net sales rose 14% YoY to record $13.1M; gross margin improved to 49% from 37%.
- Net loss $8.0M ($0.49 per share) vs $8.1M ($0.60) in Q1 2022.
- Partnerships with LeMaitre Vascular and Sientra to expand distribution of cardiovascular and SimpliDerm products.
- Nasdaq notified company its MVLS was below $35M; 180-day compliance period ends Oct 31, 2023.
- Cash balance $11.8M; FDA meeting confirmed path to resubmit CanGaroo RM 510(k).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708527/000110465923058445/0001104659-23-058445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708527/000110465923058445/tm2315197d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-058445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer